<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04701593</url>
  </required_header>
  <id_info>
    <org_study_id>19-377</org_study_id>
    <nct_id>NCT04701593</nct_id>
  </id_info>
  <brief_title>Using Triamcinolone Acetonide to Reduce Pain After Scleral Buckle Surgery</brief_title>
  <official_title>Using Intraoperative Triamcinolone Acetonide Irrigation to Reduce Post-Operative Pain From Scleral Buckle Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Polytechnic Institute and State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Polytechnic Institute and State University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      PURPOSE: Scleral buckle surgery is a widely used ophthalmic surgery for the correction of&#xD;
      rhegmatogenous retinal detachment. Studies suggest that eye pain is a common and&#xD;
      underestimated occurrence after scleral buckle surgery, but as of yet, there is no definitive&#xD;
      management method for reducing pain following scleral buckle surgery. The investigators aim&#xD;
      to control pain following scleral buckle surgery with sub-tenon's irrigation with&#xD;
      triamcinolone acetonide at the time of surgery. Using a randomized prospective clinical&#xD;
      study, the investigators test if this technique will reduce the pain, nausea/vomiting, and&#xD;
      analgesic use caused by scleral buckle surgery.&#xD;
&#xD;
      METHODS: Forty-eight patients undergoing scleral buckle surgery will be randomized into two&#xD;
      groups. The experimental group receives a sub-tenon irrigation of 1 cc 40mg/mL triamcinolone&#xD;
      acetonide around the base of the scleral buckle (0.25 cc in each quadrant) at time of&#xD;
      operation. The control group does not receive any triamcinolone irrigation. Pain scores are&#xD;
      measured 1 day post-operatively via 11-pt numerical rating scale as the primary outcome. The&#xD;
      nausea/vomiting score is measured 1 day post-operatively via standard 6-pt scale. Patients&#xD;
      track pain medication use via pill count. Values will be measured again at 1-2-week and 6&#xD;
      months post-op.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 3, 2020</start_date>
  <completion_date type="Anticipated">July 3, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 3, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Operative Pain Day 1</measure>
    <time_frame>1 Day Post-Op</time_frame>
    <description>11-point Numerical Rating Scale (0-10, 10 being highest level of pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Operative Pain Week 1</measure>
    <time_frame>1 Week Post-Op</time_frame>
    <description>11-point Numerical Rating Scale (0-10, 10 being highest level of pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Operative Pain Month 6</measure>
    <time_frame>6 Months Post-Op</time_frame>
    <description>11-point Numerical Rating Scale (0-10, 10 being highest level of pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea/Vomiting Score Day 1</measure>
    <time_frame>1 Day Post-Op</time_frame>
    <description>Standard 7-pt scale for nausea and vomiting (0-6, 6 being most nausea/vomiting)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea/Vomiting Score Week 1</measure>
    <time_frame>1 Week Post-Op</time_frame>
    <description>Standard 7-pt scale for nausea and vomiting (0-6, 6 being most nausea/vomiting)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Medication Use Day 1</measure>
    <time_frame>1 Day Post-Op</time_frame>
    <description>Pill-Count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Medication Use Week 1</measure>
    <time_frame>1 Week Post-Op</time_frame>
    <description>Pill-Count</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No additional drug given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental (Triamcinolone Acetonide)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receives a sub-tenon irrigation of 1 cc 40mg/mL triamcinolone acetonide around the base of the scleral buckle (0.25 cc in each quadrant) at time of operation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone Acetonide 40mg/mL</intervention_name>
    <description>Sub-tenon irrigation 1cc</description>
    <arm_group_label>Experimental (Triamcinolone Acetonide)</arm_group_label>
    <other_name>Kenalog</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient must have rhegmatogenous retinal detachment and be scheduled to undergo&#xD;
             scleral buckle surgery for correction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Advanced Glaucoma&#xD;
&#xD;
          -  History of corticosteroid responsive elevation in IOP&#xD;
&#xD;
          -  Allergy to Triamcinolone Acetonide or other corticosteroids&#xD;
&#xD;
          -  Pre-existing chronic pain disorders&#xD;
&#xD;
          -  Herpes zoster&#xD;
&#xD;
          -  Prior corneal allograft&#xD;
&#xD;
          -  Allergy to local anesthetic or penicillin&#xD;
&#xD;
          -  Patients unable to consent on own behalf&#xD;
&#xD;
          -  Patients unable to communicate pain and nausea levels&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Incarceration&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vishak J John, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Tech, Vistar Eye Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Parth R Vaidya</last_name>
    <phone>3363911953</phone>
    <email>vaidpr14@vt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vishak J John, MD</last_name>
    <phone>(336) 703-7429</phone>
    <email>Vishakjohn@vistareye.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vistar Eye Centers</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vishak J John, MD</last_name>
      <phone>336-703-7429</phone>
      <email>Vishakjohn@vistareye.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 5, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Scleral Buckle</keyword>
  <keyword>Triamcinolone Acetonide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

